Alkion BioInnovations

General

Jobs • 0

Shortlists/Awards • 2

Pricing strategy • 0

Partners/Competitors • 0

Last update: Dec 6, 2024 Last update: Dec 6, 2024

General

Jobs

Shortlists/Awards

Pricing strategy

Partners/Competitors

Details

Legal residence:France

Organization type:Supplier / manufacturer

Funding agencies:

Other, Horizon Europe

Other, Horizon Europe (2021 - 2027)

Sectors:

Agriculture, Energy, Food Processing & Safety, Hea ...
See more

Agriculture, Energy, Food Processing & Safety, Health, Laboratory & Measurement, Research, Science & Innovation

Nr. of employees:11-50

Sanctions:Check now

Status:

Active

Attachments • 0

About

Alkion BioPharma was founded in 2011 to revolutionize the secondary metabolims production for cancer therapies.

Imperial Innovations, a team of Imperial College researchers & business professionals joined together to develop the technologies able to transform non-GMO plants into a natural biorefinery.

Quickly the technological platform received strong interests from the cosmetics community and the company signed research contracts to develop new disruptive cosmetics ingredients.

Four years after the company was founded, boasting a strong commercial pipeline, Alkion BioPharma was acquired by Evonik Industries AG for cosmetics & food supplements applications.

The same founding team created Alkion BioInnovations in March 2017 in order to develop disruptive pharmaceutical & agri-food solutions. The company owns the exclusive rights on these applications.

In 2018, the team was granted the first historical R&D license from French authorities for their work on Cannabis and major & minor cannabinoids.